Six factors may predict invasive breast cancer recurrence after DCIS diagnosis
Six factors were associated with invasive recurrence of breast cancer after a diagnosis of ductal…
Browsing: ductal carcinoma in situ
SABCS 2018: Low-dose tamoxifen was safe and effective at reducing recurrence and new breast disease for patients with DCIS, LCIS, and ADH
Treatment with a low dose of tamoxifen (5 mg per day) halved the risk of…
Women with DCIS at lowest risk of recurrence if they are post-menopausal or have oestrogen receptor positive cancer
Patients with an early form of breast cancer are less likely to suffer a recurrence…
ASTRO updates clinical guidance on accelerated radiation therapy for breast cancer
The American Society for Radiation Oncology (ASTRO) has updated to its Evidence-Based Consensus Statement for the…
ASTRO 2016: Radiation boost reduces local tumour recurrence for DCIS patients following WBRT
A supplemental “boost” of radiation improves local control and provides an incremental benefit in decreasing…
New technology helps ID aggressive early breast cancer
When a woman is diagnosed with the earliest stage of breast cancer, how aggressive should…
AACR 2016: Delays in radiation therapy increase chance of breast tumour development in women treated for ductal carcinoma in situ
Women who underwent treatment for ductal carcinoma in situ (DCIS), a noninvasive breast abnormality, were…
New Biomarker May Predict Which Breast Precancers Will Progress
Source: AACR Measuring the presence and amount of the protein Vav2 may help identify breast…